Skip to main content

RBD and Non-synuclein Neurodegenerative Disorders: A Critical Appraisal

  • Chapter
  • First Online:
Rapid-Eye-Movement Sleep Behavior Disorder

Abstract

RBD has been proposed as an early marker of neurodegenerative diseases especially synucleinopathies, while less commonly an association has been reported between RBD and tauopathies. The RBD occurrence in disorders where there is substantial pathology in areas known to control motor aspects of REM sleep indicates that the site of neurological damage is more important that the molecular pathology. Moreover, there is a frequent overlap between synucleinopathies and tauopathies from the neuropathological standpoint. Considering together all the neurodegenerative encephalopathies, with the exception of Wilson’s disease, the most consistence feature seems that RBD associated with non-synuclein disorders occurs after the clinical disease is present, rather than before the onset of non-synuclein disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Friedman JH. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3). Mov Disord. 2002;17:1350–3.

    Article  PubMed  Google Scholar 

  2. Iranzo A, Munoz E, Santamaria J, Vilaseca I, Mila M, Tolosa E. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease. Mov Disord. 2003;18:1179–83.

    Article  PubMed  Google Scholar 

  3. Chi NF, Shiao GM, Ku HL, Soong BW. Sleep disruption in spinocerebellar ataxia type 3: a genetic and polysomnographic study. J Chin Med Assoc. 2013;76(1):25–30. https://doi.org/10.1016/j.jcma.2012.09.006.

    Article  PubMed  Google Scholar 

  4. Pedroso JL, Braga-Neto P, Martinez AR, Martins CR Jr, Rezende Filho FM, Sobreira-Neto MA, Prado LB, do Prado GF, França MC Jr, Barsottini OG. Sleep disorders in Machado-Joseph disease. Curr Opin Psychiatry. 2016;29:402–8. https://doi.org/10.1097/YCO.0000000000000287.

    Article  PubMed  Google Scholar 

  5. Minz M, Autret A, Laff ont F, Beillevaire T, Cathala HP, Castaigne P. A study on sleep in amyotrophic lateral sclerosis. Biomedicine. 1979;30:40–6.

    PubMed  CAS  Google Scholar 

  6. Sforza E, Krieger J, Petiau C. REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev. 1997;1:57–69.

    Article  CAS  PubMed  Google Scholar 

  7. Ebben MR, Shahbazi M, Lange DJ, Krieger AC. REM behavior disorder associated with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:473–4. https://doi.org/10.3109/17482968.2012.673172.

    Article  CAS  PubMed  Google Scholar 

  8. Puligheddu M, Congiu P, Aricò D, Rundo F, Borghero G, Marrosu F, Fantini ML, Ferri R. Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med. 2016;26:16–22. https://doi.org/10.1016/j.sleep.2016.05.016.

    Article  PubMed  Google Scholar 

  9. Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, La Bella V, Ferri R. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135:219–24. https://doi.org/10.1111/ane.12593.

    Article  PubMed  CAS  Google Scholar 

  10. Tribl GG, Bor-Seng-Shu E, Trindade MC, Lucato LT, Teixeira MJ, Barbosa ER. Wilson’s disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuropsiquiatr. 2014;72:653–8.

    Article  PubMed  Google Scholar 

  11. Tribl GG, Trindade MC, Bittencourt T, Lorenzi-Filho G, Cardoso Alves R, Ciampi de Andrade D, Fonoff ET, Bor-Seng-Shu E, Machado AA, Schenck CH, Teixeira MJ, Barbosa ER. Wilson’s disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med. 2016;17:179–85. https://doi.org/10.1016/j.sleep.2015.09.003.

    Article  PubMed  Google Scholar 

  12. Evans E, Mowat D, Wilson M, Einfeld S. Sleep disturbance in Mowat-Wilson syndrome. Am J Med Genet A. 2016;170(3):654–60. https://doi.org/10.1002/ajmg.a.37502.

    Article  PubMed  Google Scholar 

  13. Limongi JC. REM sleep behavior disorder, neurodegeneration and Wilson’s disease. Arq Neuropsiquiatr. 2014;72(9):649–50.

    Article  PubMed  Google Scholar 

  14. Nevsimalova S, Buskova J, Bruha R, Kemlink D, Sonka K, Vitek L, Marecek Z. Sleep disorders in Wilson’s disease. Eur J Neurol. 2011;18:184–90. https://doi.org/10.1111/j.1468-1331.2010.03106.x.

    Article  PubMed  CAS  Google Scholar 

  15. Arnulf I, Nielsen J, Lohmann E, Schiefer J, Wild E, Jennum P, Konofal E, Walker M, Oudiette D, Tabrizi S, Durr A. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;65(4):482–8. https://doi.org/10.1001/archneur.65.4.482.

    Article  PubMed  Google Scholar 

  16. Piano C, Losurdo A, Della Marca G, Solito M, Calandra-Buonaura G, Provini F, Bentivoglio AR, Cortelli P. Polysomnographic findings and clinical correlates in Huntington disease: a cross-sectional cohort study. Sleep. 2015;38:1489–95. https://doi.org/10.5665/sleep.4996.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1–9.

    Article  CAS  PubMed  Google Scholar 

  18. Gross RA, Spehlmann R, Daniels JC. Sleep disturbances in progressive supranuclear palsy. Electroencephalogr Clin Neurophysiol. 1978;45:16–25.

    Article  CAS  PubMed  Google Scholar 

  19. Laffont F, Autret A, Minz M, Beillevaire T, Gilbert A, Cathala HP, Castaigne P. Polygraphic sleep recordings in 9 cases of Steele-Richardson’s disease. Rev Neurol (Paris). 1979;135:127–42.

    CAS  Google Scholar 

  20. Laffont F, Leger JM, Penicaud A, et al. Sleep abnormalities and evoked potentials (VEP-BAER-SEP) in progressive supranuclear palsy. Neurophysiol Clin. 1988;18:255–69.

    Article  CAS  PubMed  Google Scholar 

  21. Shimizu T, Inami Y, Sugita Y, Iijima S, Teshima Y, Matsuo R, Yasoshima A, Egawa I, Okawa M, Tashiro T, et al. REM sleep without muscle atonia (stage 1-REM) and its relation to delirious behavior during sleep in patients with degenerative diseases involving the brain stem. Jpn J Psychiatry Neurol. 1990;44:681–92.

    PubMed  CAS  Google Scholar 

  22. Shimizu T, Sugita Y, Iijima S, Teshima Y, Hishikawa Y. Sleep study in patients with spinocerebellar degeneration and related diseases. In: Koella WP, editor. Sleep. Basel: S Karger; 1981. p. 435–7.

    Google Scholar 

  23. Pareja JA, Caminero AB, Masa JF, Dobato JL. A first case of progressive supranuclear palsy and pre- clinical REM sleep behavior disorder presenting as inhibition of speech during wakefulness and somniloquy with phasic muscle twitching during REM sleep. Neurologia. 1996;11:304–6.

    PubMed  CAS  Google Scholar 

  24. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–9.

    Article  PubMed  Google Scholar 

  25. Arnulf I, Merino-Andreu M, Bloch F, Konofal E, Vidailhet M, Cochen V, Derenne JP, Agid Y. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep. 2005;28:349–54.

    Article  PubMed  Google Scholar 

  26. Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med. 2009;10:407–15. https://doi.org/10.1016/j.sleep.2008.05.004.

    Article  PubMed  Google Scholar 

  27. Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain. 2005;128:239e49.

    Article  Google Scholar 

  28. Mann DM, Yates PO, Hawkes J. The pathology of the human locus coeruleus. Clin Neuropathol. 1983;2:1e7.

    Google Scholar 

  29. Schenck CH, Garcia-Rill E, Skinner RD, Anderson ML, Mahowald MW. A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer’s disease: postmortem brain stem histochemical analyses. Biol Psychiatry. 1996;40(5):422.

    Article  CAS  PubMed  Google Scholar 

  30. Schenck CH, Mahowald MW, Anderson ML, Silber MH, Boeve BF, Parisi JE. Lewy body variant of Alzheimer’s disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder. Biol Psychiatry. 1997;42:527–8.

    Article  CAS  PubMed  Google Scholar 

  31. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder (RBD): 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–8. https://doi.org/10.1016/j.sleep.2012.10.009.

    Article  PubMed  Google Scholar 

  32. Gagnon JF, Petit D, Fantini ML, Rompré S, Gauthier S, Panisset M, Robillard A, Montplaisir J. REM sleep behaviour disorder and REM sleep without atonia in Alzheimer’s disease. Sleep. 2006;29:1321–5.

    Article  PubMed  Google Scholar 

  33. Sinforiani E, Terzaghi E, Pasotti C, Zucchella C, Zambrelli E, Manni R. Hallucinations and sleep-wake cycle disturbances in Alzheimer’s disease: a questionnaire based study in 218 patients. Neurol Sci. 2007;28:96–9.

    Article  CAS  PubMed  Google Scholar 

  34. Wang P, Wing YK, Xing J, Liu Y, Zhou B, Zhang Z, Yao H, Guo Y, Shang Y, Zhang X. Rapid eye movement sleep behavior disorder in patients with probable Alzheimer's disease. Aging Clin Exp Res. 2016;28(5):951–7. https://doi.org/10.1007/s40520-015-0382-8.

    Article  PubMed  Google Scholar 

  35. Kim HJ, Im HK, Kim J, Han JY, de Leon M, Deshpande A, Moon WJ. Brain atrophy of secondary REM-sleep behavior disorder in neurodegenerative disease. J Alzheimers Dis. 2016;52:1101–9. https://doi.org/10.3233/JAD-151197.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.

    Article  PubMed  Google Scholar 

  37. Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OM, Yamada M. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer’s disease. Brain Res. 2009;1251:1–6. https://doi.org/10.1016/j.brainres.2008.11.055.

    Article  PubMed  CAS  Google Scholar 

  38. Galbiati A, Carli G, Hensley M, Ferini-Strambi L. REM Sleep Behavior Disorder and Alzheimer’s Disease: Definitely No Relationship. J Alzheimers Dis. 2018;63(1):1–11. https://doi.org/10.3233/JAD-171164.

    Article  PubMed  Google Scholar 

  39. Kimura K, Tachibana N, Aso T, Kimura J, Shibasaki H. Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration. Sleep. 1997;20:891–4. 107.

    Article  CAS  PubMed  Google Scholar 

  40. Wetter TC, Brunner H, Collado-Seidel V, Trenkwalder C, Winkelmann J. Sleep and periodic limb movements in corticobasal degeneration. Sleep Med. 2002;3:33–6.

    Article  PubMed  Google Scholar 

  41. Gatto EM, Uribe Roca C, Martinez O. Subclinical REM sleep behavior disorder (RBD) in two patients with corticobasal degeneration (CBD). Mov Disord. 2005;20(Suppl 10):S107.

    Google Scholar 

  42. Munhoz RP, Teive HA. REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism? Clin Neurol Neurosurg. 2014;127:71–4. https://doi.org/10.1016/j.clineuro.2014.09.014.

    Article  PubMed  Google Scholar 

  43. Caparros-Lefebvre D, Elbaz A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet. 1999;354(9175):281–6.

    Article  CAS  PubMed  Google Scholar 

  44. Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain. 2002;125(Pt 4):801–11.

    Article  PubMed  Google Scholar 

  45. Lannuzel A, Hoglinger GU, Verhaeghe S, et al. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain. 2007;130(Pt 3):816–27.

    Article  PubMed  Google Scholar 

  46. Lannuzel A, Michel PP, Höglinger GU, Champy P, Jousset A, Medja F, Lombès A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Neuroscience. 2003;121(2):287–96.

    Article  CAS  PubMed  Google Scholar 

  47. Höglinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, Féger J, Champy P, Prigent A, Medja F, Lombes A, Oertel WH, Ruberg M, Hirsch EC. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem. 2005;95:930–9.

    Article  CAS  PubMed  Google Scholar 

  48. De Cock VC, Lannuzel A, Verhaeghe S, Roze E, Ruberg M, Derenne JP, Willer JC, Vidailhet M, Arnulf I. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep. 2007;30(8):1026–32.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Salva MA, Guilleminault C. Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia. Neurology. 1986;36:576–7.

    Article  CAS  PubMed  Google Scholar 

  50. Wszolek ZK, Pfeiffer RF, Bhatt MH, et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol. 1992;32:312–20.

    Article  CAS  PubMed  Google Scholar 

  51. Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. Arch Neurol. 2002;59:943–50.

    Article  PubMed  Google Scholar 

  52. Foster N, Wilhelmsen K, Sima A, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol. 1997;41:706–15.

    Article  CAS  PubMed  Google Scholar 

  53. Reed LA, Schmidt ML, Wszolek ZK, Balin BJ, Soontornniyomkij V, Lee VM, Trojanowski JQ, Schelper RL. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (“pallido-ponto-nigral degeneration”). J Neuropathol Exp Neurol. 1998;57:588–601.

    Article  CAS  PubMed  Google Scholar 

  54. Boeve BF, Lin SC, Strongosky A, Dickson DW, Wszolek Z. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch Neurol. 2006;63:268–72.

    Article  PubMed  Google Scholar 

  55. Lo Coco D, Cupidi C, Mattaliano A, Baiamonte V, Realmuto S, Cannizzaro E. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci. 2012;33:371–3. https://doi.org/10.1007/s10072-011-0702-5.

    Article  PubMed  Google Scholar 

  56. Daoud H, Postuma RB, Bourassa CV, Rochefort D, Gauthier MT, Montplaisir J, Gagnon JF, Arnulf I, Dauvilliers Y, Charley CM, Inoue Y, Sasai T, Högl B, Desautels A, Frauscher B, Cochen De Cock V, Rouleau GA, Dion PA. C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder. Can J Neurol Sci. 2014;41:759–62. https://doi.org/10.1017/cjn.2014.39.

    Article  PubMed  Google Scholar 

  57. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chiò A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD, Morrison KE, Pall H, Talbot K, Ansorge O, Chromosome 9-ALS/FTD Consortium, French research network on FTLD/FTLD/ALS, ITALSGEN Consortium, Hernandez DG, Arepalli S, Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, Van Deerlin VM, Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji S, Le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30. https://doi.org/10.1016/S1474-4422(12)70043-1.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Claassen DO, Parisi JE, Giannini C, Boeve BF, Dickson DW, Josephs KA. Frontotemporal dementia mimicking dementia with Lewy bodies. Cogn Behav Neurol. 2008;21:157–63.

    Article  PubMed  Google Scholar 

  59. Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Mahowald MW, Dauvilliers Y, Graff-Radford NR, Wszolek ZK, Parisi JE, Dugger B, Murray ME, Dickson DW. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14:754–62. https://doi.org/10.1016/j.sleep.2012.10.015.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Landolt HP, Glatzel M, Blättler T, Achermann P, Roth C, Mathis J, Weis J, Tobler I, Aguzzi A, Bassetti CL. Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66:1418–249.

    Article  PubMed  Google Scholar 

  61. Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, Bucelli RC. Sleep pathology in Creutzfeldt-Jakob disease. J Clin Sleep Med. 2016;12:1033–9. https://doi.org/10.5664/jcsm.5944.

    Article  PubMed  PubMed Central  Google Scholar 

  62. The ALS CNTF Treatment Study (ACTS) Phase I–II Study Group. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141–7.

    Article  Google Scholar 

  63. Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;1607:75–93. https://doi.org/10.1016/j.brainres.2014.10.009.

    Article  PubMed  CAS  Google Scholar 

  64. Laferriere F, Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med Wkly. 2015;145:w14054. https://doi.org/10.4414/smw.2015.14054.

    Article  PubMed  CAS  Google Scholar 

  65. Ferri R, Gagnon JF, Postuma RB, Rundo F, Montplaisir JY. Comparison between an automatic and a visual scoring method of the chin muscle tone during rapid eye movement sleep. Sleep Med. 2014;15:661–5. https://doi.org/10.1016/j.sleep.2013.12.022.

    Article  PubMed  Google Scholar 

  66. Luppi PH, Clément O, Sapin E, Gervasoni D, Peyron C, Léger L, Salvert D, Fort P. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Med Rev. 2011;15:153–63. https://doi.org/10.1016/j.smrv.2010.08.002.

    Article  PubMed  Google Scholar 

  67. Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, Guillot-Noël L, Russaouen O, Bruneteau G, Pradat PF, Le Forestier N, Vandenberghe N, Danel-Brunaud V, Guy N, Thauvin-Robinet C, Lacomblez L, Couratier P, Hannequin D, Seilhean D, Le Ber I, Corcia P, Camu W, Brice A, Rouleau G, LeGuern E, Meininger V. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554–60. https://doi.org/10.1136/jmg.2010.077180.

    Article  PubMed  CAS  Google Scholar 

  68. Walker FO. Huntington’s disease. Semin Neurol. 2007;27:143–50.

    Article  PubMed  Google Scholar 

  69. Taylor N, Bramble D. Sleep disturbance and Huntingdon’s disease. Br J Psychiatry. 1997;171:393.

    Article  CAS  PubMed  Google Scholar 

  70. Emser W, Brenner M, Stober T, Schimrigk K. Changes in nocturnal sleep in Huntington’s and Parkinson’s disease. J Neurol. 1988;235:177–9.

    Article  CAS  PubMed  Google Scholar 

  71. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington’s disease. J Neurosci. 2005;25:157–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Goodman AO, Rogers L, Pilsworth S, McAllister CJ, Shneerson JM, Morton AJ, Barker RA. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington’s disease. Curr Neurol Neurosci Rep. 2011;11:211–7. https://doi.org/10.1007/s11910-010-0163-x.

    Article  PubMed  Google Scholar 

  73. Neutel D, Tchikviladze M, Charles P, et al. Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder. Sleep Med. 2015;16:754–9. https://doi.org/10.1016/j.sleep.2014.12.021.

    Article  PubMed  Google Scholar 

  74. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5:344–50.

    Article  CAS  PubMed  Google Scholar 

  75. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–88.

    Article  CAS  PubMed  Google Scholar 

  76. Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15–54. https://doi.org/10.1111/j.1749-6632.2009.05115.x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Scherfler C, Frauscher B, Schocke M, Iranzo A, Gschliesser V, Seppi K, Santamaria J, Tolosa E, Högl B, Poewe W, SINBAR (Sleep Innsbruck Barcelona) Group. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol. 2011;69:400–7. https://doi.org/10.1002/ana.22245.

    Article  PubMed  Google Scholar 

  78. García-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, Pita Lobo P, Poupon C, Benali H, Arnulf I, Vidailhet M, Lehericy S. The coeruleus/subcoeruleus complex in rapid eye movement sleeps behaviour disorders in Parkinson’s disease. Brain. 2013;136:2120–9. https://doi.org/10.1093/brain/awt152.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Svetel M, Mijajlović M, Tomić A, Kresojević N, Pekmezović T, Kostić VS. Transcranial sonography in Wilson’s disease. Parkinsonism Relat Disord. 2012;18:234–8. https://doi.org/10.1016/j.parkreldis.2011.10.007.

    Article  PubMed  Google Scholar 

  80. Kim H, Yun JY, Choi KG, Koo H, Han HJ. Sleep related Problems as Nonmotor Symptom of Dentatorubropallidoluysian Atrophy. J Korean Med Sci. 2018;11:33(17):e130. https://doi.org/10.3346/jkms.2018.33.e130.

  81. Li X, James S, Lei PJ. Interactions between α-synuclein and tau protein: implications to neurodegenerative disorders. Mol Neurosci. 2016;60:298–304. https://doi.org/10.1007/s12031-016-0829-1.

    Article  CAS  Google Scholar 

  82. Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI. Tau protein: relevance to Parkinson’s disease. Int J Biochem Cell Biol. 2010;42(11):1775–8. https://doi.org/10.1016/j.biocel.2010.07.016.

    Article  PubMed  CAS  Google Scholar 

  83. Coakeley S, Strafella AP. Imaging tau pathology in Parkinsonisms. NPJ Parkinsons Dis. 2017;3:22. https://doi.org/10.1038/s41531-017-0023-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luigi Ferini-Strambi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ferini-Strambi, L., Casoni, F.M., Zucconi, M. (2019). RBD and Non-synuclein Neurodegenerative Disorders: A Critical Appraisal. In: Schenck, C., Högl, B., Videnovic, A. (eds) Rapid-Eye-Movement Sleep Behavior Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90152-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90152-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90151-0

  • Online ISBN: 978-3-319-90152-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics